March 20, 2023 article Open access Glucocorticoids for IgA nephropathy—pro Kidney International DOI: 10.1016/j.kint.2023.01.018 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 1 stored of 24 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access IgA nephropathy 2023 Nature Reviews Disease Primers review Medicine Renal Diseases and Glomerulopathies Open access 246 citations 1 result References 3 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy 2022 JAMA article Medicine Renal Diseases and Glomerulopathies Open access cited by 1 patent 360 citations Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy 2022 Kidney International article Medicine Renal Diseases and Glomerulopathies Open access 226 citations After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathy 2020 Kidney International article Medicine Renal Diseases and Glomerulopathies Open access cited by 2 patents 214 citations 3 results